Answers are grounded in this paper and cite their sources.
Comparative analysis explores troponin elevation after noncardiac surgery, highlighting the potential detection of undetected patients at risk.
Troponin elevation after noncardiac surgery is associated with an elevated risk of 30-day mortality. Little is known about relative merit of using a high-sensitivity Troponin T (hsTnT), the fifth-generation assay, vs the nonhigh sensitivity Troponin T (non-hsTnT), the fourth-generation assay, in the noncardiac surgery setting. We aimed to identify whether hsTnT can identify additional patients at risk that would have gone undetected with non-hsTnT measurement.
No takes yet. Share an insight, caveat, or question.
Borges et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: